Starry Gene Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A2

  • Investors
  • 12

Starry Gene General Information

Description

Developer of gene therapy drugs designed for the treatment of ophthalmic diseases. The company utilizes adeno-associated virus vectors, bispecific antibody optimization, capsid screening, gene editing, targeted-reca enhanced homology-directed repair, and base editing, enabling healthcare providers to reduce injection frequency and achieve long-term therapeutic outcomes for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Huisheng Building, Advanced Technology Research Institute, University of Science and
  • Technology of China, Number 5089 Wangjiang West Road, High-tech Zone
  • Hefei, Anhui 230088
  • China
+86 0551
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Huisheng Building, Advanced Technology Research Institute, University of Science and
  • Technology of China, Number 5089 Wangjiang West Road, High-tech Zone
  • Hefei, Anhui 230088
  • China
+86 0551

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starry Gene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A2) 12-Sep-2025 Completed Generating Revenue
5. Early Stage VC 29-Feb-2024 Completed Generating Revenue
4. Early Stage VC 17-Jun-2022 Completed Generating Revenue
3. Early Stage VC 23-Mar-2022 Completed Generating Revenue
2. Early Stage VC 09-Nov-2020 $4.48M $4.48M Completed Generating Revenue
1. Accelerator/Incubator 01-Aug-2019 Completed Startup
To view Starry Gene’s complete valuation and funding history, request access »

Starry Gene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Starry Gene Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guoyao Venture Capital Venture Capital Minority
KSCY Holding Group Asset Manager Minority
The Chinese Academy of Sciences Venture Capital Management Venture Capital Minority
Co-Win Ventures Venture Capital Minority
Hefei Innovation Technology Venture Capital Growth/Expansion Minority
You’re viewing 5 of 12 investors. Get the full list »

Starry Gene FAQs

  • When was Starry Gene founded?

    Starry Gene was founded in 2019.

  • Where is Starry Gene headquartered?

    Starry Gene is headquartered in Hefei, China.

  • What is the size of Starry Gene?

    Starry Gene has 30 total employees.

  • What industry is Starry Gene in?

    Starry Gene’s primary industry is Drug Discovery.

  • Is Starry Gene a private or public company?

    Starry Gene is a Private company.

  • What is Starry Gene’s current revenue?

    The current revenue for Starry Gene is .

  • How much funding has Starry Gene raised over time?

    Starry Gene has raised $4.48M.

  • Who are Starry Gene’s investors?

    Guoyao Venture Capital, KSCY Holding Group, The Chinese Academy of Sciences Venture Capital Management, Co-Win Ventures, and Hefei Innovation Technology Venture Capital are 5 of 12 investors who have invested in Starry Gene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process